| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $480.6M | +14.5% |
| R&D Expense | $121.5M | +3.5% |
| SG&A Expense | $79.9M | +4.3% |
| Operating Income | -$6.6M | +88.6% |
| Pre-tax Income | -$8.9M | +84.0% |
| Income Tax | -$11.2M | -514.1% |
| Net Income | $2.3M | +103.9% |
| EPS (Basic) | $0.04 | +103.9% |
| EPS (Diluted) | $0.04 | +103.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.8M | -12.3% |
| Accounts Receivable | $97.5M | +32.4% |
| Current Assets | $279.8M | +37.7% |
| Total Assets | $663.8M | +70.9% |
| Current Liabilities | $183.2M | +60.7% |
| Long-term Debt | $2.7M | +37.2% |
| Total Liabilities | $326.6M | +164.2% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $78.8M | +143.4% |
| Capital Expenditures | $11.1M | +27.5% |
| Investing Cash Flow | -$161.9M | -572.0% |
| Financing Cash Flow | $72.9M | +734.3% |
| Free Cash Flow | $67.7M | +186.0% |
| $337.2M |
| +27.3% |